Research and development progress of SARS-CoV-2 neutralizing antibody

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has widely spread around the world, exerting great impacts on economic growth and human life. It is the highest priority to develop safe and effective drugs. Neutralizing antibodies have achieved good results in previous clinical applications of some viral infectious diseases. They can be used not only for the short-term prevention of SARS-COV-2 infection, but also for the treatment of corona virus disease 2019 (COVID-19), showing important application value. At present, the research and development of SARS-CoV-2 neutralizing antibody has made its rapid progress in China and abroad. Many antibody drugs have entered clinical trials and been put into emergency use. This article mainly summarizes targets of SARS-CoV-2 neutralizing antibody, screening technologies, drug development progresses and problems to be concerned.